PERINATAL TRIALS REPORT

PT0424

Docosaheaxaenoic acid (DHA) for the improvement of neurodevelopmental outcome in preterm infants: the DINO trial

Plain Language Summary:     

This study aims to determine the amount of DHA that is most beneficial for a preterm infant to grow and develop. DHA is a fat found in breast milk, in some infant formulas as well as in fish and fish oils. There is evidence that the type of fat a baby consumes affects the blalance of fats in blood or may be important for their growth preterm and development. This study will help determine what amount of DHA enables a baby to grow and develop best.

Trial status:            Open to accrual      

Date trial opened to accrual: January 2004

Expected accrual period: Approximately 2 years

Trial Objective:       To determine the effect of meeting the calculated DHA requirement of preterm infatns on neurdevelopment at 18 months corrected age as assessed by the Baylely Scales of Infant Development (BSID)

Type of administration:        Multi-centre national

Principal Investigator/s:       

Dr Maria Makrides

Email: makridesm@mail.wch.sa.gov.au

A/Prof Robert Gibson

Email: rgibson@flinders.edu.au

Contact Person/s:               

Suzanne MsCusker

Email: cnrctrials@mail.wch.sa.gov.au

© IMPACT/PSANZ 2001